Caption Management’s BioLife Solutions BLFS Stock Holding History

Caption Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32,500	Closed	-$603K	–	1171
2024 Q1	$603K	Hold	32,500	–	–	0.01%	839
2023 Q4	$528K	Buy	+32,500	New	+$415K	0.01%	949
2023 Q3	–	Sell	-7,035	Closed	-$155K	–	1276
2023 Q2	$155K	Buy	+7,035	New	+$148K	﹤0.01%	954

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Caption Management's BLFS Position: Q2 2024 in Review

Caption Management sold out of BioLife Solutions (BLFS) in Q2 2024, closing a stake of 32,500 shares — an estimated $603K sold.

Caption Management first reported a position in BLFS in Q2 2023 and held it in 3 quarters. The position peaked at $603K in Q1 2024. 164 funds tracked by Wall St. Rank hold BLFS as of Q2 2024.

Caption Management reported no remaining BioLife Solutions position as of Q2 2024 after selling out during the quarter.
Caption Management sold 32,500 BioLife Solutions shares in Q2 2024, an estimated $603K.
Caption Management first reported a position in BioLife Solutions in Q2 2023 and held it in 3 quarters.
Caption Management's BioLife Solutions position peaked at $603K in Q1 2024.
164 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.